Key terms

About BRTX

BioRestorative Therapies, Inc. engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company's initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process. BioRestorative Therapies was founded on June 13, 1997 and is headquartered in Melville, NY.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BRTX news

Apr 17 4:05pm ET Optimistic Outlook for BioRestorative Therapies Backed by Clinical and Strategic Advances by TipRanks Apr 16 11:31am ET BioRestorative’s BRTX-100 trial to use sham injection control, says Roth MKM by TipRanks Apr 16 7:50am ET BioRestorative announces FDA clearance of Phase 2 BRTX-100 study protocol by TipRanks Apr 08 7:47am ET BioRestorative partners with Galen Patient Recruitment for BRTX-100 trial by TipRanks Apr 03 4:39pm ET BioRestorative Therapies files registration statement of Form S-1 by TipRanks Apr 03 4:20pm ET BioRestorative Therapies files to sell 2.51M shares of common stock for holders by TipRanks Mar 12 7:42am ET BioRestorative Therapies Clarifies Disclosure Regulations Impact by TipRanks Feb 09 4:38am ET BioRestorative Therapies Sparks Investor Interest with New Transaction by TipRanks Feb 09 4:38am ET BioRestorative Therapies Secures $8.1M Through Warrant Restructuring by TipRanks Feb 06 2:46pm ET Promising Early Phase 2 Results for BioRestorative Therapies’ BRTX-100 Lead to Buy Rating by TipRanks Feb 06 8:27am ET BioRestorative announces exercise of warrants, issuance of new warrants by TipRanks Feb 06 4:18am ET BioRestorative Therapies Clarifies Disclosure Liability Limits by TipRanks Feb 05 7:32am ET BioRestorative presents preliminary data from Phase 2 study of BRTX-100 by TipRanks Feb 01 7:32am ET BioRestorative Therapies to present preliminary BRTX-100 data at ORS meeting by TipRanks
Jan 17 4:29am ET BioRestorative Therapies to Present in The Jan 26th Virtual Investor Summit Microcap Event by NewsFile

BRTX Financials

1-year income & revenue

Key terms

BRTX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BRTX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days